Circulating MicroRNAs as a Novel Class of Diagnostic Biomarkers in Gastrointestinal Tumors Detection: A Meta-Analysis Based on 42 Articles
By Ran Wang, Hong-Lin Wen, Yongcheng Xu, Qiulan Chen, Yingchun Luo, Yiqin Lin, Yu-Hao Luo, An-gao Xu. PLoS ONE, 2014
6,811 citations recorded by the source corpus.
Objective MicroRNAs (miRNAs) have become the focus of most recent efforts in cancer research. However, there have been inconsistencies in the literature regarding the suitability of circulating miRNAs for early detection of gastrointestinal cancers. This study aims to assess the diagnostic performance of circulating miRNAs in detection of gastrointestinal cancer through a meta-analysis. Methods Eligible studies were selected by conducting a systematic literature search of public databases. The sensitivity and specificity were used to plot the summary receiver operator characteristic (SROC) curve and calculate the area under the SROC curve (AUC). The between-study heterogeneity was evaluated by Q test and I 2 statistics. Subgroup analyses and meta-regression were further performed to explore the potential sources of heterogeneity. All analyses were performed using the STATA 12.0 software. Results A total of 107 studies from 42 articles were included for the meta-analysis according to the inclusion criteria. The overall analysis of all gastrointestinal cancers showed that circulating miRNAs have a relatively good diagnostic performance in gastrointestinal cancers, with a sensitivity of 0.75, a specificity of 0.81 and an AUC of 0.85. In addition, subgroup analyses based on different type of miRNA assay suggested that single-miRNA assay displayed a relatively low diagnostic performance with the AUC values of 0.84 for gastric cancer (GC) and 0.79 for colorectal cancer (CRC), while multiple-miRNAs assay significantly improved the diagnosing accuracy with AUC rising to 0.92 for GC and 0.89 for CRC. Another interesting finding was that plasma-based miRNA assay reach a higher accuracy compared with serum-based one for GC, while opposite conclusion was drawn for CRC. Conclusions In conclusion, circulating miRNAs, particularly the combination of multiple miRNAs, may present as promising biomarkers for the diagnosis of gastrointestinal cancers. Further large-scale prospective studies are necessary to validate their potential applicability in human cancer diagnosis.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/e2d81d8bcc2c9396d5ea7e92eecf8a29342ab58d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Molecular Biology
Citations in the corpus
- A diagnostic meta-analysis of the Patient Health Questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. (2015, methodology): “Quality assessment was conducted at the study level and used criteria based on the QUADAS-II [15].”
- Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist (2014, methodology): “, primary or secondary care), and number of centres, is important to allow for proper assessment of the applicability and thus generalizability of the study findings [40,41,56,72].”
- False-negative results of initial RT-PCR assays for COVID-19: A systematic review (2020, methodology): “We evaluated the methodological quality using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool [30].”
- Sensitivity, Specificity, and Predictive Values: Foundations, Pliabilities, and Pitfalls in Research and Practice (2017, background): “Because there can be concerns about the validity of these so-called gold standards (3, 4), they have increasingly been referred to less glowingly as reference standards (5), thus removing what seemed to be unreserved endorsement.”
- Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. (2015, methodology): “Quality assessment of the included studies was performed by two independent reviewers using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool for diagnostic accuracy studies [20].”